SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-047735
Filing Date
2021-09-13
Accepted
2021-09-13 17:58:25
Documents
1
Period of Report
2021-09-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4044
  Complete submission text file 0001213900-21-047735.txt   5532
Mailing Address BAUSCH HEALTH COMPANIES INC. 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
VON ESCHENBACH ANDREW C. (Reporting) CIK: 0001536529 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38914 | Film No.: 211250651

Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations